Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
16.08
-0.48 (-2.90%)
At close: Nov 20, 2024, 4:00 PM
16.00
-0.08 (-0.50%)
After-hours: Nov 20, 2024, 4:50 PM EST
CRBP Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for CRBP stock have an average target of 65.86, with a low estimate of 40 and a high estimate of 88. The average target predicts an increase of 309.58% from the current stock price of 16.08.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 23, 2024.
Analyst Ratings
The average analyst rating for CRBP stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +397.51% | Sep 23, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $85 → $40 | Strong Buy | Maintains | $85 → $40 | +148.76% | Sep 20, 2024 |
| Wedbush | Wedbush | Buy Maintains $85 → $51 | Buy | Maintains | $85 → $51 | +217.16% | Sep 20, 2024 |
| Mizuho | Mizuho | Buy Reiterates $74 | Buy | Reiterates | $74 | +360.20% | Sep 20, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $82 | Buy | Reiterates | $82 | +409.95% | Sep 20, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
1.70M
EPS This Year
-3.79
from -10.31
EPS Next Year
-5.04
from -3.79
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 10.5M | 26.3M | ||
| Avg | n/a | 1.7M | 6.3M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 1,444.1% | ||
| Avg | - | - | 270.0% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.40 | -2.66 | -3.26 | ||
| Avg | -3.79 | -5.04 | -4.86 | ||
| Low | -4.21 | -10.97 | -8.19 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.